- Home
- APA vs PCVX Comparison
APA vs PCVX Comparison
Compare APA & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APA
- PCVX
- Stock Information
- Founded
- APA 1954
- PCVX 2013
- Country
- APA United States
- PCVX United States
- Employees
- APA N/A
- PCVX N/A
- Industry
- APA Oil & Gas Production
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- APA Energy
- PCVX Health Care
- Exchange
- APA Nasdaq
- PCVX Nasdaq
- Market Cap
- APA 5.6B
- PCVX 4.5B
- IPO Year
- APA N/A
- PCVX 2020
- Fundamental
- Price
- APA $17.76
- PCVX $30.90
- Analyst Decision
- APA Hold
- PCVX Strong Buy
- Analyst Count
- APA 17
- PCVX 10
- Target Price
- APA $24.44
- PCVX $136.50
- AVG Volume (30 Days)
- APA 8.5M
- PCVX 2.1M
- Earning Date
- APA 05-07-2025
- PCVX 05-07-2025
- Dividend Yield
- APA 5.63%
- PCVX N/A
- EPS Growth
- APA N/A
- PCVX N/A
- EPS
- APA 2.76
- PCVX N/A
- Revenue
- APA $10,148,000,000.00
- PCVX N/A
- Revenue This Year
- APA N/A
- PCVX N/A
- Revenue Next Year
- APA N/A
- PCVX N/A
- P/E Ratio
- APA $6.43
- PCVX N/A
- Revenue Growth
- APA 24.91
- PCVX N/A
- 52 Week Low
- APA $13.58
- PCVX $27.66
- 52 Week High
- APA $33.41
- PCVX $121.06
- Technical
- Relative Strength Index (RSI)
- APA 55.31
- PCVX 38.80
- Support Level
- APA $15.20
- PCVX $28.64
- Resistance Level
- APA $18.73
- PCVX $33.75
- Average True Range (ATR)
- APA 0.63
- PCVX 2.54
- MACD
- APA 0.40
- PCVX 0.87
- Stochastic Oscillator
- APA 72.52
- PCVX 32.60
About APA APA Corporation
APA Corp is an independent exploration and production company. It develops, and produces crude oil, natural gas, and natural gas liquids. The Company's business has oil and gas operations in three geographic areas: the United States (U.S.), Egypt, and offshore the U.K. in the North Sea (North Sea). APA also has active development, exploration, and appraisal operations ongoing in Suriname, as well as exploration interests in Uruguay, Alaska, and other international locations.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.